Tofacitinib Impurity 6

Tofacitinib Impurity 6 Basic information
Product Name:Tofacitinib Impurity 6
Synonyms:Tofacitinib Impurity 39;N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine;Tofacitinib-21;Tofacitinib impurity 14/5,6-Dihydro Tofacitinib/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile;Tofacitinib impurity 15/5,6-Dihydro Tofacitinib Citrate/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate;5,6-Dihydro CP-690550;3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile;Tofacitinib Related Compound 21
CAS:1640972-35-5
MF:C16H22N6O
MW:314.39
EINECS:
Product Categories:
Mol File:1640972-35-5.mol
Tofacitinib Impurity 6 Structure
Tofacitinib Impurity 6 Chemical Properties
Melting point >80°C (dec.)
Boiling point 583.2±50.0 °C(Predicted)
density 1.239±0.06 g/cm3(Predicted)
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
pka6.04±0.60(Predicted)
form Solid
color Pale Yellow to Yellow
Safety Information
MSDS Information
Tofacitinib Impurity 6 Usage And Synthesis
Uses5,6-Dihydro CP-690550 is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.
Tofacitinib Impurity 6 Preparation Products And Raw materials
Tofacitinib related coMpound 2 Tofacitinib Impurity 2 Tofacitinib Related Compound 18 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile Methyl (4-Methylpiperidin-3-yl)carbaMate 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-[2-(2-methoxyphenoxy)ethylamino]-3-(9-methylcarbazol-4-yl)oxypropan-2-ol:hydrochloride 3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 13-Deoxyepirubicin Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Tofacitinib Impurity 3

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.